Intuitive Surgical (NASDAQ:ISRG) Price Target Raised to $560.00 at UBS Group

Intuitive Surgical (NASDAQ:ISRG) had its target price upped by equities researchers at UBS Group from $500.00 to $560.00 in a research note issued to investors on Monday. The firm presently has a “neutral” rating on the medical equipment provider’s stock. UBS Group’s price target points to a potential downside of 2.54% from the company’s previous close.

A number of other equities analysts also recently commented on the stock. Mizuho upped their price objective on shares of Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. Leerink Partners raised their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a report on Monday. Barclays lifted their price objective on shares of Intuitive Surgical from $610.00 to $674.00 in a report on Monday. Finally, Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $610.95.

Intuitive Surgical Trading Down 1.6 %

ISRG stock traded down $9.46 on Monday, hitting $574.59. The company’s stock had a trading volume of 1,391,095 shares, compared to its average volume of 1,954,819. The firm has a 50 day moving average of $547.16 and a two-hundred day moving average of $505.21. Intuitive Surgical has a 1 year low of $364.17 and a 1 year high of $616.00. The stock has a market cap of $204.66 billion, a price-to-earnings ratio of 92.27, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39.

Insider Transactions at Intuitive Surgical

In other news, CFO Jamie Samath sold 108 shares of the firm’s stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the sale, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at $4,746,819.42. This trade represents a 1.22 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction dated Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,967,734. The trade was a 6.39 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 42,453 shares of company stock valued at $22,059,506. 0.90% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Intuitive Surgical

A number of large investors have recently bought and sold shares of ISRG. Berbice Capital Management LLC purchased a new stake in Intuitive Surgical in the fourth quarter worth $26,000. Godsey & Gibb Inc. grew its position in shares of Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. bought a new position in Intuitive Surgical during the third quarter valued at approximately $33,000. Decker Retirement Planning Inc. bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at approximately $36,000. Finally, Capital Performance Advisors LLP bought a new stake in shares of Intuitive Surgical in the 3rd quarter valued at approximately $38,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.